000			01768nam a2200229Ia 4500
003			NULRC
005			20250520103015.0
008			250520s9999 xx 000 0 und d
020			_a9781108749060
040			_cNULRC
050			_aR 855.3 .B87 2020
245		4	_aThe Business of healthcare innovation / _cedited by Lawton Robert Burns
250			_aThird Edition
260			_aCambridge, United Kingdom : _bCambridge University Press, _cc2020
300			_a492 pages : _billustrations ; _c25 cm.
365			_bUSD35
504			_aIncludes bibliographical references and index.
505			_a1. Product suppliers in the health care value chain Lawton Robert Burns -- 2. The pharmaceutical sector Richard T. Evans and Scott Hinds -- 3. The biotechnology sector - therapeutics Cary G. Pfeffer -- 4. New venture creation in biotechnology Jason Rhodes and Lawton Robert Burns -- 5. The medical device sector Kurt H. Kruger and Max A. Kruger -- 6. Financing medtech innovation Justin Klein -- 7. The healthcare information technology sector Adam C. Powell and John Glaser.
520			_aPerhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional _6.3 billion in funding for the National Institutes of Health (NIH) and other agencies
650			_aBUSINESS FORECASTING
942			_2lcc _cBK
999			_c21180 _d21180